Indication
Chronic phase chronic myeloid leukemia
Chronic phase chronic myeloid leukemia is an indolent, initial stage of a clonal myeloproliferative neoplasm originating in bone marrow hematopoietic stem cells. Read more about Chronic phase chronic myeloid leukemia
4 drugs 4 manufacturers
Drugs that treat it
Common Chronic phase chronic myeloid leukemia therapies.
ICLUSIG (ponatinib HCl)
ICLUSIG (ponatinib HCl)
ICLUSIG (ponatinib HCl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonChronic phase chronic myeloid leukemia is an indolent, initial stage of a clonal myeloproliferative neoplasm originating in bone marrow hematopoietic stem cells.
It predominantly affects adults and is pathophysiologically driven by the Philadelphia chromosome—a reciprocal balanced translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2)—which generates the constitutively active BCR::ABL1 tyrosine kinase oncogene.
This molecular driver induces unchecked granulocytic proliferation while preserving cell maturation, typically presenting with marked granulocytic leukocytosis, basophilia, or splenomegaly.
Clinically defined by fewer than 10% immature blast cells in the peripheral blood and bone marrow, patients in this phase are often asymptomatic or present with mild constitutional symptoms.
- cancer.gov
Chronic phase chronic myeloid leukemia is an indolent, initial stage of a clonal myeloproliferative neoplasm originating in bone marrow hematopoietic stem cells Clinically defined by fewer than 10% immature blast cells in the peripheral blood and bone marrow, patients in this phase are often asymptomatic or present with mild constitutional symptoms
- nih.gov
Chronic phase chronic myeloid leukemia is an indolent, initial stage of a clonal myeloproliferative neoplasm originating in bone marrow hematopoietic stem cells It predominantly affects adults and is pathophysiologically driven by the Philadelphia chromosome—a reciprocal balanced translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2)—which generates the constitutively active BCR::ABL1 tyrosine kinase oncogene
- nih.gov
Chronic phase chronic myeloid leukemia is an indolent, initial stage of a clonal myeloproliferative neoplasm originating in bone marrow hematopoietic stem cells It predominantly affects adults and is pathophysiologically driven by the Philadelphia chromosome—a reciprocal balanced translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2)—which generates the constitutively active BCR::ABL1 tyrosine kinase oncogene Clinically defined by fewer than 10% immature blast cells in the peripheral blo...
- nih.gov
It predominantly affects adults and is pathophysiologically driven by the Philadelphia chromosome—a reciprocal balanced translocation between chromosomes 9 and 22, t(9;22)(q34;q11.2)—which generates the constitutively active BCR::ABL1 tyrosine kinase oncogene
- nih.gov
This molecular driver induces unchecked granulocytic proliferation while preserving cell maturation, typically presenting with marked granulocytic leukocytosis, basophilia, or splenomegaly
- youtube.com
This molecular driver induces unchecked granulocytic proliferation while preserving cell maturation, typically presenting with marked granulocytic leukocytosis, basophilia, or splenomegaly
- youtube.com
This molecular driver induces unchecked granulocytic proliferation while preserving cell maturation, typically presenting with marked granulocytic leukocytosis, basophilia, or splenomegaly
Personalize your experience
Follow Chronic phase chronic myeloid leukemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.